Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth

Abstract

BackgroundThere is an estimate of three to five million people who inject drugs living in Asia. Unsafe injecting drug use is a major driver of both the HIV and hepatitis C (HCV) epidemic in this region, and an increase in incidence among people who inject drugs continues. Although harm reduction is becoming increasingly accepted, a largely punitive policy remains firmly in place, undermining access to life-saving programmes. The aim of this study is to present an overview of key findings on harm reduction in Asia based on data collected for the Global State of Harm Reduction 2014.MethodsA review of international scientific and grey literature was undertaken between May and September 2014, including reports from multilateral agencies and international non-governmental organisations. A qualitative survey comprising open-ended questions was also administered to civil society, harm reduction networks, and organisations of people who use drugs to obtain national and regional information on key developments in harm reduction. Expert consultation from academics and key thinkers on HIV, drug use, and harm reduction was used to verify findings.ResultsIn 2014, 17 countries in Asia provide needle and syringe programmes (NSP) provision and 15 opioid substitution therapy (OST). It is estimated that between 60 and 90 % of people who use drugs in Asia have HCV; however, treatment still remains out of reach due to cost barriers. TB testing and treatment services are yet to be established for key populations, yet nearly 15 % of the global burden of new cases of HIV-TB co-infection are attributed to southeast Asia. Eighteen percent of the total number of people living with HIV eligible for antiretroviral treatment (ART) accessed treatment. Only Malaysia and Indonesia provide OST in prison, with no NSP provision in prisons in the region.ConclusionTo reduce HIV and viral hepatitis risk among people who inject drugs, there is a necessity to significantly increase harm reduction service provision in Asia. Although there has been progress, work still needs to be done to ensure an appropriate and enabling environment. At present, people who inject drugs are extremely difficult to reach; structural and legal barriers to services must be reduced, integrated holistic services introduced, and further research undertaken.Electronic supplementary materialThe online version of this article (doi:10.1186/s12954-015-0066-x) contains supplementary material, which is available to authorized users.

Syndemic and Synergistic Effects of Intimate Partner Violence, Crystal Methamphetamine, and Depression on HIV Sexual Risk Behaviors among Women Who Inject Drugs in Indonesia

“…In the Indonesian context, the implementation of responsive and tailored interventions for women who use and inject drugs is hindered by structural and legal barriers [ 86 ]. The criminalization of people who use drugs tends to drive the most marginalized members of the population further away from health and support services due to fear of arrest [ 87 ].…”

A systematic review of selected human rights programs to improve HIV-related outcomes from 2003 to 2015: what do we know?

“…Human rights-related barriers that inhibit access to, uptake of and adherence to HIV services among key and vulnerable populations have been well documented [33, 34]. Examples include stigmatizing sex workers and men who have sex with men in health facilities [35, 36], illegal policing practices that target people who inject drugs [37], and lack of knowledge and implementation of harm reduction policies [38]. These barriers indirectly influence HIV-related outcomes by discouraging engagement in prevention, care and treatment services [39, 40].…”

Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: A latent class analysis

“…In addition to substance use, mental health— and depression in particular— is closely associated with high-risk sexual and drug behaviors in Kazakhstan (Shaw et al, 2017a; Stein et al, 2003) and other countries (Armstrong et al, 2013; Brady et al, 2016; Ulibarri et al, 2015). Drug use patterns, particularly mixing opioids with ephedrine and sedatives prior to injection, increases risk of HIV transmission and overdose amongst PWID in Central Asia because it lowers inhibitions and impairs judgment to practice safe sex and injection drug risk behaviors (UNODC, 2008; Tavitian-Exley et al, 2015; Stone, 2016; Coffin, 2008). …”